+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Spasticity Treatment Market 2024-2028

  • PDF Icon

    Report

  • 173 Pages
  • December 2023
  • Region: Global
  • TechNavio
  • ID: 5557997
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The spasticity treatment market is forecasted to grow by USD 1.61 bn during 2023-2028, accelerating at a CAGR of 5.5% during the forecast period. The report on the spasticity treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing incidence of chronic diseases and health conditions, the availability of advanced technologies for drug delivery, and the introduction of botulinum toxins and cannabinoids.

The spasticity treatment market is segmented as below:

By Type

  • Drug therapy
  • Physical therapy
  • Surgical treatment

By End-user

  • Hospitals
  • Ambulatory surgical centers
  • Home care settings
  • Specialty clinics
  • Diagnostic centers

By Geography

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the advent of neurostimulation devices for spasticity treatment as one of the prime reasons driving the spasticity treatment market growth during the next few years. Also, growing awareness of spasticity and telemedicine and remote monitoring for spasticity treatment will lead to sizable demand in the market.

The report on the spasticity treatment market covers the following areas:

  • Spasticity treatment market sizing
  • Spasticity treatment market forecast
  • Spasticity treatment market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading spasticity treatment market vendors that include Abbott Laboratories, Axonics Inc., BioWave Ltd., Boston Scientific Corp., BrainsWay Ltd., electroCore Inc., LivaNova Plc, Mayo Clinic, Medtronic Plc, NEURONETICS Inc., Nevro Corp., OMRON Corp., PathMaker Neurosystems Inc., Rady Childrens Hospital San Diego, Saebo Inc, Saluda Medical Pty Ltd., ShiraTronics, The Johns Hopkins Health System Corp., Theranica Bio Electronics Ltd., and Thync Global Inc.. Also, the spasticity treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape and an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global spasticity treatment market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global spasticity treatment market 2018 - 2022 ($ billion)
4.2 Type Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
4.3 End-user Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Type
6.1 Market segments
Exhibit 30: Chart on Type - Market share 2023-2028 (%)
Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Drug therapy - Market size and forecast 2023-2028
Exhibit 34: Chart on Drug therapy - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Drug therapy - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Drug therapy - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Drug therapy - Year-over-year growth 2023-2028 (%)
6.4 Physical therapy - Market size and forecast 2023-2028
Exhibit 38: Chart on Physical therapy - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Physical therapy - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Physical therapy - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Physical therapy - Year-over-year growth 2023-2028 (%)
6.5 Surgical treatment - Market size and forecast 2023-2028
Exhibit 42: Chart on Surgical treatment - Market size and forecast 2023-2028 ($ billion)
Exhibit 43: Data Table on Surgical treatment - Market size and forecast 2023-2028 ($ billion)
Exhibit 44: Chart on Surgical treatment - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Surgical treatment - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Type
Exhibit 46: Market opportunity by Type ($ billion)
Exhibit 47: Data Table on Market opportunity by Type ($ billion)
7 Market Segmentation by End-user
7.1 Market segments
Exhibit 48: Chart on End-user - Market share 2023-2028 (%)
Exhibit 49: Data Table on End-user - Market share 2023-2028 (%)
7.2 Comparison by End-user
Exhibit 50: Chart on Comparison by End-user
Exhibit 51: Data Table on Comparison by End-user
7.3 Hospitals - Market size and forecast 2023-2028
Exhibit 52: Chart on Hospitals - Market size and forecast 2023-2028 ($ billion)
Exhibit 53: Data Table on Hospitals - Market size and forecast 2023-2028 ($ billion)
Exhibit 54: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
7.4 Ambulatory surgical centers - Market size and forecast 2023-2028
Exhibit 56: Chart on Ambulatory surgical centers - Market size and forecast 2023-2028 ($ billion)
Exhibit 57: Data Table on Ambulatory surgical centers - Market size and forecast 2023-2028 ($ billion)
Exhibit 58: Chart on Ambulatory surgical centers - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Ambulatory surgical centers - Year-over-year growth 2023-2028 (%)
7.5 Home care settings - Market size and forecast 2023-2028
Exhibit 60: Chart on Home care settings - Market size and forecast 2023-2028 ($ billion)
Exhibit 61: Data Table on Home care settings - Market size and forecast 2023-2028 ($ billion)
Exhibit 62: Chart on Home care settings - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Home care settings - Year-over-year growth 2023-2028 (%)
7.6 Specialty clinics - Market size and forecast 2023-2028
Exhibit 64: Chart on Specialty clinics - Market size and forecast 2023-2028 ($ billion)
Exhibit 65: Data Table on Specialty clinics - Market size and forecast 2023-2028 ($ billion)
Exhibit 66: Chart on Specialty clinics - Year-over-year growth 2023-2028 (%)
Exhibit 67: Data Table on Specialty clinics - Year-over-year growth 2023-2028 (%)
7.7 Diagnostic centers - Market size and forecast 2023-2028
Exhibit 68: Chart on Diagnostic centers - Market size and forecast 2023-2028 ($ billion)
Exhibit 69: Data Table on Diagnostic centers - Market size and forecast 2023-2028 ($ billion)
Exhibit 70: Chart on Diagnostic centers - Year-over-year growth 2023-2028 (%)
Exhibit 71: Data Table on Diagnostic centers - Year-over-year growth 2023-2028 (%)
7.8 Market opportunity by End-user
Exhibit 72: Market opportunity by End-user ($ billion)
Exhibit 73: Data Table on Market opportunity by End-user ($ billion)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 75: Chart on Market share by geography 2023-2028 (%)
Exhibit 76: Data Table on Market share by geography 2023-2028 (%)
9.2 Geographic comparison
Exhibit 77: Chart on Geographic comparison
Exhibit 78: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 79: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 83: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 87: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 95: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 China - Market size and forecast 2023-2028
Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Exhibit 103: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 104: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 105: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
Exhibit 107: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 108: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 109: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 110: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 Germany - Market size and forecast 2023-2028
Exhibit 111: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 112: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 113: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 114: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity by geography
Exhibit 115: Market opportunity by geography ($ billion)
Exhibit 116: Data Tables on Market opportunity by geography ($ billion)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 117: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 119: Overview on factors of disruption
11.4 Industry risks
Exhibit 120: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 121: Vendors covered
12.2 Market positioning of vendors
Exhibit 122: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 123: Abbott Laboratories - Overview
Exhibit 124: Abbott Laboratories - Business segments
Exhibit 125: Abbott Laboratories - Key news
Exhibit 126: Abbott Laboratories - Key offerings
Exhibit 127: Abbott Laboratories - Segment focus
12.4 Axonics Inc.
Exhibit 128: Axonics Inc. - Overview
Exhibit 129: Axonics Inc. - Business segments
Exhibit 130: Axonics Inc. - Key offerings
Exhibit 131: Axonics Inc. - Segment focus
12.5 Boston Scientific Corp.
Exhibit 132: Boston Scientific Corp. - Overview
Exhibit 133: Boston Scientific Corp. - Business segments
Exhibit 134: Boston Scientific Corp. - Key news
Exhibit 135: Boston Scientific Corp. - Key offerings
Exhibit 136: Boston Scientific Corp. - Segment focus
12.6 BrainsWay Ltd.
Exhibit 137: BrainsWay Ltd. - Overview
Exhibit 138: BrainsWay Ltd. - Product / Service
Exhibit 139: BrainsWay Ltd. - Key offerings
12.7 electroCore Inc.
Exhibit 140: electroCore Inc. - Overview
Exhibit 141: electroCore Inc. - Product / Service
Exhibit 142: electroCore Inc. - Key offerings
12.8 LivaNova Plc
Exhibit 143: LivaNova Plc - Overview
Exhibit 144: LivaNova Plc - Business segments
Exhibit 145: LivaNova Plc - Key offerings
Exhibit 146: LivaNova Plc - Segment focus
12.9 Medtronic Plc
Exhibit 147: Medtronic Plc - Overview
Exhibit 148: Medtronic Plc - Business segments
Exhibit 149: Medtronic Plc - Key news
Exhibit 150: Medtronic Plc - Key offerings
Exhibit 151: Medtronic Plc - Segment focus
12.10 NEURONETICS Inc.
Exhibit 152: NEURONETICS Inc. - Overview
Exhibit 153: NEURONETICS Inc. - Product / Service
Exhibit 154: NEURONETICS Inc. - Key offerings
12.11 Nevro Corp.
Exhibit 155: Nevro Corp. - Overview
Exhibit 156: Nevro Corp. - Product / Service
Exhibit 157: Nevro Corp. - Key offerings
12.12 OMRON Corp.
Exhibit 158: OMRON Corp. - Overview
Exhibit 159: OMRON Corp. - Business segments
Exhibit 160: OMRON Corp. - Key news
Exhibit 161: OMRON Corp. - Key offerings
Exhibit 162: OMRON Corp. - Segment focus
12.13 PathMaker Neurosystems Inc.
Exhibit 163: PathMaker Neurosystems Inc. - Overview
Exhibit 164: PathMaker Neurosystems Inc. - Product / Service
Exhibit 165: PathMaker Neurosystems Inc. - Key offerings
12.14 Saebo Inc
Exhibit 166: Saebo Inc - Overview
Exhibit 167: Saebo Inc - Product / Service
Exhibit 168: Saebo Inc - Key offerings
12.15 Saluda Medical Pty Ltd.
Exhibit 169: Saluda Medical Pty Ltd. - Overview
Exhibit 170: Saluda Medical Pty Ltd. - Product / Service
Exhibit 171: Saluda Medical Pty Ltd. - Key offerings
12.16 ShiraTronics
Exhibit 172: ShiraTronics - Overview
Exhibit 173: ShiraTronics - Product / Service
Exhibit 174: ShiraTronics - Key offerings
12.17 Theranica Bio Electronics Ltd.
Exhibit 175: Theranica Bio Electronics Ltd. - Overview
Exhibit 176: Theranica Bio Electronics Ltd. - Product / Service
Exhibit 177: Theranica Bio Electronics Ltd. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 178: Inclusions checklist
Exhibit 179: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 180: Currency conversion rates for US$
13.4 Research methodology
Exhibit 181: Research methodology
Exhibit 182: Validation techniques employed for market sizing
Exhibit 183: Information sources
13.5 List of abbreviations
Exhibit 184: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market by Geography
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Historic Market Size - Data Table on global spasticity treatment market 2018 - 2022 ($ billion)
Exhibits 19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
Exhibits 20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Type - Market share 2023-2028 (%)
Exhibits 31: Data Table on Type - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Type
Exhibits 33: Data Table on Comparison by Type
Exhibits 34: Chart on Drug therapy - Market size and forecast 2023-2028 ($ billion)
Exhibits 35: Data Table on Drug therapy - Market size and forecast 2023-2028 ($ billion)
Exhibits 36: Chart on Drug therapy - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Drug therapy - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Physical therapy - Market size and forecast 2023-2028 ($ billion)
Exhibits 39: Data Table on Physical therapy - Market size and forecast 2023-2028 ($ billion)
Exhibits 40: Chart on Physical therapy - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Physical therapy - Year-over-year growth 2023-2028 (%)
Exhibits 42: Chart on Surgical treatment - Market size and forecast 2023-2028 ($ billion)
Exhibits 43: Data Table on Surgical treatment - Market size and forecast 2023-2028 ($ billion)
Exhibits 44: Chart on Surgical treatment - Year-over-year growth 2023-2028 (%)
Exhibits 45: Data Table on Surgical treatment - Year-over-year growth 2023-2028 (%)
Exhibits 46: Market opportunity by Type ($ billion)
Exhibits 47: Data Table on Market opportunity by Type ($ billion)
Exhibits 48: Chart on End-user - Market share 2023-2028 (%)
Exhibits 49: Data Table on End-user - Market share 2023-2028 (%)
Exhibits 50: Chart on Comparison by End-user
Exhibits 51: Data Table on Comparison by End-user
Exhibits 52: Chart on Hospitals - Market size and forecast 2023-2028 ($ billion)
Exhibits 53: Data Table on Hospitals - Market size and forecast 2023-2028 ($ billion)
Exhibits 54: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits 55: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits 56: Chart on Ambulatory surgical centers - Market size and forecast 2023-2028 ($ billion)
Exhibits 57: Data Table on Ambulatory surgical centers - Market size and forecast 2023-2028 ($ billion)
Exhibits 58: Chart on Ambulatory surgical centers - Year-over-year growth 2023-2028 (%)
Exhibits 59: Data Table on Ambulatory surgical centers - Year-over-year growth 2023-2028 (%)
Exhibits 60: Chart on Home care settings - Market size and forecast 2023-2028 ($ billion)
Exhibits 61: Data Table on Home care settings - Market size and forecast 2023-2028 ($ billion)
Exhibits 62: Chart on Home care settings - Year-over-year growth 2023-2028 (%)
Exhibits 63: Data Table on Home care settings - Year-over-year growth 2023-2028 (%)
Exhibits 64: Chart on Specialty clinics - Market size and forecast 2023-2028 ($ billion)
Exhibits 65: Data Table on Specialty clinics - Market size and forecast 2023-2028 ($ billion)
Exhibits 66: Chart on Specialty clinics - Year-over-year growth 2023-2028 (%)
Exhibits 67: Data Table on Specialty clinics - Year-over-year growth 2023-2028 (%)
Exhibits 68: Chart on Diagnostic centers - Market size and forecast 2023-2028 ($ billion)
Exhibits 69: Data Table on Diagnostic centers - Market size and forecast 2023-2028 ($ billion)
Exhibits 70: Chart on Diagnostic centers - Year-over-year growth 2023-2028 (%)
Exhibits 71: Data Table on Diagnostic centers - Year-over-year growth 2023-2028 (%)
Exhibits 72: Market opportunity by End-user ($ billion)
Exhibits 73: Data Table on Market opportunity by End-user ($ billion)
Exhibits 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 75: Chart on Market share by geography 2023-2028 (%)
Exhibits 76: Data Table on Market share by geography 2023-2028 (%)
Exhibits 77: Chart on Geographic comparison
Exhibits 78: Data Table on Geographic comparison
Exhibits 79: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 80: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 81: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 82: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 83: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 84: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 85: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 86: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 87: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 88: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 89: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 90: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 95: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 96: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 97: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 98: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 99: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits 100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits 101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 102: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 103: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits 104: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits 105: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 106: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 107: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits 108: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits 109: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 110: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 111: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits 112: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits 113: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 114: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 115: Market opportunity by geography ($ billion)
Exhibits 116: Data Tables on Market opportunity by geography ($ billion)
Exhibits 117: Impact of drivers and challenges in 2023 and 2028
Exhibits 118: Overview on Criticality of inputs and Factors of differentiation
Exhibits 119: Overview on factors of disruption
Exhibits 120: Impact of key risks on business
Exhibits 121: Vendors covered
Exhibits 122: Matrix on vendor position and classification
Exhibits 123: Abbott Laboratories - Overview
Exhibits 124: Abbott Laboratories - Business segments
Exhibits 125: Abbott Laboratories - Key news
Exhibits 126: Abbott Laboratories - Key offerings
Exhibits 127: Abbott Laboratories - Segment focus
Exhibits 128: Axonics Inc. - Overview
Exhibits 129: Axonics Inc. - Business segments
Exhibits 130: Axonics Inc. - Key offerings
Exhibits 131: Axonics Inc. - Segment focus
Exhibits 132: Boston Scientific Corp. - Overview
Exhibits 133: Boston Scientific Corp. - Business segments
Exhibits 134: Boston Scientific Corp. - Key news
Exhibits 135: Boston Scientific Corp. - Key offerings
Exhibits 136: Boston Scientific Corp. - Segment focus
Exhibits 137: BrainsWay Ltd. - Overview
Exhibits 138: BrainsWay Ltd. - Product / Service
Exhibits 139: BrainsWay Ltd. - Key offerings
Exhibits 140: electroCore Inc. - Overview
Exhibits 141: electroCore Inc. - Product / Service
Exhibits 142: electroCore Inc. - Key offerings
Exhibits 143: LivaNova Plc - Overview
Exhibits 144: LivaNova Plc - Business segments
Exhibits 145: LivaNova Plc - Key offerings
Exhibits 146: LivaNova Plc - Segment focus
Exhibits 147: Medtronic Plc - Overview
Exhibits 148: Medtronic Plc - Business segments
Exhibits 149: Medtronic Plc - Key news
Exhibits 150: Medtronic Plc - Key offerings
Exhibits 151: Medtronic Plc - Segment focus
Exhibits 152: NEURONETICS Inc. - Overview
Exhibits 153: NEURONETICS Inc. - Product / Service
Exhibits 154: NEURONETICS Inc. - Key offerings
Exhibits 155: Nevro Corp. - Overview
Exhibits 156: Nevro Corp. - Product / Service
Exhibits 157: Nevro Corp. - Key offerings
Exhibits 158: OMRON Corp. - Overview
Exhibits 159: OMRON Corp. - Business segments
Exhibits 160: OMRON Corp. - Key news
Exhibits 161: OMRON Corp. - Key offerings
Exhibits 162: OMRON Corp. - Segment focus
Exhibits 163: PathMaker Neurosystems Inc. - Overview
Exhibits 164: PathMaker Neurosystems Inc. - Product / Service
Exhibits 165: PathMaker Neurosystems Inc. - Key offerings
Exhibits 166: Saebo Inc - Overview
Exhibits 167: Saebo Inc - Product / Service
Exhibits 168: Saebo Inc - Key offerings
Exhibits 169: Saluda Medical Pty Ltd. - Overview
Exhibits 170: Saluda Medical Pty Ltd. - Product / Service
Exhibits 171: Saluda Medical Pty Ltd. - Key offerings
Exhibits 172: ShiraTronics - Overview
Exhibits 173: ShiraTronics - Product / Service
Exhibits 174: ShiraTronics - Key offerings
Exhibits 175: Theranica Bio Electronics Ltd. - Overview
Exhibits 176: Theranica Bio Electronics Ltd. - Product / Service
Exhibits 177: Theranica Bio Electronics Ltd. - Key offerings
Exhibits 178: Inclusions checklist
Exhibits 179: Exclusions checklist
Exhibits 180: Currency conversion rates for US$
Exhibits 181: Research methodology
Exhibits 182: Validation techniques employed for market sizing
Exhibits 183: Information sources
Exhibits 184: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global spasticity treatment market: Abbott Laboratories, Axonics Inc., BioWave Ltd., Boston Scientific Corp., BrainsWay Ltd., electroCore Inc., LivaNova Plc, Mayo Clinic, Medtronic Plc, NEURONETICS Inc., Nevro Corp., OMRON Corp., PathMaker Neurosystems Inc., Rady Childrens Hospital San Diego, Saebo Inc, Saluda Medical Pty Ltd., ShiraTronics, The Johns Hopkins Health System Corp., Theranica Bio Electronics Ltd., and Thync Global Inc.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is the advent of neurostimulation devices for spasticity treatment.'

According to the report, one of the major drivers for this market is the growing incidence of chronic diseases and health conditions.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape and a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Axonics Inc.
  • BioWave Ltd.
  • Boston Scientific Corp.
  • BrainsWay Ltd.
  • electroCore Inc.
  • LivaNova Plc
  • Mayo Clinic
  • Medtronic Plc
  • NEURONETICS Inc.
  • Nevro Corp.
  • OMRON Corp.
  • PathMaker Neurosystems Inc.
  • Rady Childrens Hospital San Diego
  • Saebo Inc
  • Saluda Medical Pty Ltd.
  • ShiraTronics
  • The Johns Hopkins Health System Corp.
  • Theranica Bio Electronics Ltd.
  • Thync Global Inc.